HAUMANN BRETT K 4
4 · Theravance Biopharma, Inc. · Filed Nov 21, 2018
Insider Transaction Report
Form 4
HAUMANN BRETT K
SVP, Clinical Development
Transactions
- Tax Payment
Ordinary Shares
2018-11-20$24.79/sh−7,368$182,653→ 134,911 total
4 · Theravance Biopharma, Inc. · Filed Nov 21, 2018
Ordinary Shares